Tom Cohen

ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers

—

by

Tom Cohen
in

The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *